| ARCHETYPE ID | openEHR-EHR-CLUSTER.sequencing_assay.v1 |
|---|---|
| Concept | Sequencing assay |
| Description | To record details of the sequencing analysis including a list of all tested genes if panel sequencing was performed. |
| Use | One or more instances of this archetype may be nested within the 'Testing details' SLOT in the OBSERVATION.laboratory_test_result. |
| Misuse | Used only to document the analysis protocol but not to document the results of the sequence analysis. The results are documented with the archetype 'genetic variant'. |
| Purpose | To record details of the performed sequencing analysis including a list of all tested genes if panel sequencing was performed. |
| References | |
| Copyright | © openEHR Foundation |
| Authors | Author name: Aurelie Tomczak Organisation: Institute of Pathology, University Hospital Heidelberg Email: au.tomczak@yahoo.com Date originally authored: 2019-06-24 |
| Other Details Language | Author name: Aurelie Tomczak Organisation: Institute of Pathology, University Hospital Heidelberg Email: au.tomczak@yahoo.com Date originally authored: 2019-06-24 |
| Other Details (Language Independent) |
|
| Keywords | Sequencing, Genomics, Panel, Assay, Pathology, Sequencing analysis, Panel sequencing, Gene, Specimen |
| Lifecycle | published |
| UID | d34e4579-c62d-4723-98a5-3501445b9eae |
| Language used | en |
| Citeable Identifier | 1246.145.506 |
| Revision Number | 1.0.1 |
| items | |
| Sequencing technology | Sequencing technology: Name of the technology used for sequencing analysis. Choice of:
|
| Sequencing or analysis device | Sequencing or analysis device: Used to specify devices and tools used for the sequencing analysis or result annotation. e.g. Sequencing device, alignment method, variant caller Include: openEHR-EHR-CLUSTER.device.v1 and specialisations |
| Kit name | Kit name: Name of the kit used for the experiment. Choice of:
|
| Nucleic acid | Nucleic acid: Type of nucleic acid used for sequencing, e.g. DNA, RNA oder cf-DNA. Choice of:
|
| Tumor cell percentage | Tumor cell percentage: To record the tumor cell content in percent. min: >=0; max: <=100 |
| Tested Genes | Tested Genes: List of all tested genes, if panel sequencing was performed. |
| Gene symbol | Gene symbol: The official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name. |
| Gene name | Gene name: The full gene name approved by the HGNC that convey the character or function of the gene. |
| Gene reference sequence | Gene reference sequence: Structured details on the reference sequence of the gene. Include: openEHR-EHR-CLUSTER.reference_ |
| Tested Region | Tested Region: List of all tested regions, if panel sequencing was performed. |
| Chromosomal location | Chromosomal location: Chromosomal location of tested region. Choice of:
|
| Start | Start: Start position of the tested region. |
| End | End: End position of the tested region. |
| Reference sequence of region | Reference sequence of region: Structured details on the reference sequence of the region. Include: openEHR-EHR-CLUSTER.reference_ |
| Extensions | Extensions: Additional details to be captured. Include: All not explicitly excluded archetypes |
| Comment | Comment: Comment on the sequencing assay that was not captured in other fields. |
| Other contributors | Simon Schumacher, HiGHmed, Germany Christina Jaeger-Schmidt, Heidelberg University Hospital, Germany Gideon Giacomelli, Charité Berlin, Germany Florian Kaercher, Charité Berlin, Germany Heather Leslie, Atomica Informatics, Australia (openEHR Editor) Ian McNicoll, freshEHR Clinical Informatics, United Kingdom (openEHR Editor) Silje Ljosland Bakke, Nasjonal IKT HF, Norway (openEHR Editor) Francesca Frexia, CRS4 - Center for advanced studies, research and development in Sardinia, Italy Cecilia Mascia, CRS4, Italy (openEHR Editor) Paolo Uva, CRS4, Italy Gianluigi Zanetti, CRS4, Italy |
| Translators |